Lin BioScience, Inc. (TPEX:6696)
143.50
-3.50 (-2.38%)
At close: Feb 14, 2025
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 11.17 billion as of February 21, 2025. Its market cap has increased by 28.83% in one year.
Market Cap
11.17B
Enterprise Value
8.86B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
143.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 11.17B, an increase of 283.10%. That is a compound annual growth rate of 23.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 209.72B |
Caliway Biopharmaceuticals | 142.08B |
Bora Pharmaceuticals Co., LTD. | 89.70B |
Lotus Pharmaceutical | 71.92B |
Lumosa Therapeutics | 39.86B |
Oneness Biotech | 38.63B |
Polaris Group | 36.08B |
Pegavision | 30.30B |